Researchers have indicated in a new study that a COPD Assessment Test-based definition of chronic bronchitis (CAT-CB) is more ...

Congress demonstrated that just under 50% of people assessed through the FRONTIER Hull Programme were diagnosed with chronic obstructive pulmonary disease (COPD) following a previous assessment via ...

Background Chronic obstructive pulmonary disease (COPD) is a leading cause of global mortality, yet existing risk prediction models remain limited. This study aimed to develop and validate a ...

The University of the Sunshine Coast has begun trialling a three in one inhaler to target better lung and heart health outcomes in chronic obstructive ...

China: Severe emphysema, quantitatively assessed using high-resolution computed tomography (HRCT), is a strong independent ...

Research reveals strong connections between muscle strength and cognitive function in patients with COPD, highlighting the potential for rehabilitation strategies.

At the European Respiratory Society Congress 2025, Lucilla Piccari, MD, PhD, a pulmonologist at Hospital del Mar in Barcelona ...

Diabetes mellitus (DM) is a possible risk factor for post-COVID-19 pulmonary fibrosis (PCPF), according to meta-analysis study findings published in BMC Pulmonary Medicine.

Bronchiectasis guidelines are inconsistent with regard to the effectiveness of mucoactive agents, and their use varies ...

Mucoactive agents did little to stave off pulmonary exacerbations of non-cystic fibrosis bronchiectasis, the CLEAR trial ...

Analysts' ratings for Pulmonx (NASDAQ:LUNG) over the last quarter vary from bullish to bearish, as provided by 6 analysts. The table below offers a condensed view of their recent ratings, showcasing ...